Individual research recommendation details

Recommendation ID

IPG752/01

Question

Evidence on the safety and efficacy of biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer is limited in quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page.

Any explanatory notes
(if applicable)

Further research could be in the form of randomised controlled trials or observational data studies including registry studies and real-world evidence. It should report details of patient selection, choice of
radiotherapy technique and device used, improvement in quality of life, and long-term efficacy and safety. It should also identify high-risk groups who might benefit.

Source guidance details

Comes from guidance

Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer

Number

IPG752

Date issued

February 2023

Other details